Prognostic Relevance of Immunophenotype and 6q Deletions in Waldenstrom's Macroglobulinemia

被引：0
|
作者：
Jiang, A. [1 ]
Qi, C. [1 ]
Trieu, Y. [1 ]
Xu, W. [1 ]
Reece, D. [1 ]
Chen, C. [1 ]
Chang, H. [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1360
引用
收藏
页码：304A / 304A
页数：1
相关论文
共 50 条
  • [31] Prognostic factors and indications for treatment of Waldenstrom's Macroglobulinemia
    Kyle, Robert A.
    Ansell, Stephen M.
    Kapoor, Prashant
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2016, 29 (02) : 179 - 186
  • [32] International prognostic scoring system for Waldenstrom's macroglobulinemia
    Morel, P.
    Duhamel, A.
    Gobbi, P.
    Dimopoulos, M.
    Dhodapkar, M.
    Mccoy, J.
    Ocio, E.
    Garcia-Sanz, R.
    Leblond, V.
    Kyle, R.
    Barlogie, B.
    Merlini, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 84 - 84
  • [33] 6q deletion in Waldenstrom Macroglobulinemia is the most common cytogenetic abnormality and is associated with aggressive disease with a trend towards worse survival
    Schop, RFJ
    Ocio, EM
    Gonzalez, B
    Gutierrez, NC
    Moro, MJ
    Aguilera, C
    Hernández, J
    García-Sanz, RG
    Xu, RF
    Hernandez-Rivas, JM
    Greipp, PR
    Dispenzieri, A
    Jalal, SM
    Lacy, MQ
    Gonzalez-Paz, N
    Gertz, MA
    San Miguel, JF
    Fonseca, R
    BLOOD, 2005, 106 (11) : 290A - 290A
  • [34] MYD88 L265P Mutations Are Correlated with 6q Deletion in Korean Patients with Waldenstrom Macroglobulinemia
    Kim, Jung-Ah
    Im, Kyongok
    Park, Si Nae
    Kwon, Jiseok
    Choi, Qute
    Hwang, Sang Mee
    Sekiguchi, Naohiro
    Yoon, Sung-Soo
    Lee, Dong Soon
    Kim, Seon Young
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [35] 6q deletions in pediatric acute lymphoblastic leukemia.
    Calero, T
    Heyman, M
    Merup, M
    Grandér, D
    Rasool, O
    Söderhäll, S
    Gahrton, G
    Einhorn, S
    BLOOD, 1999, 94 (10) : 188B - 188B
  • [36] Identification and characterization of proximal 6q deletions in prostate cancer
    Cooney, KA
    Wetzel, JC
    Consolino, CM
    Wojno, KJ
    CANCER RESEARCH, 1996, 56 (18) : 4150 - 4153
  • [37] 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas
    Merup, M
    Moreno, TC
    Heyman, M
    Rönnberg, K
    Grandér, D
    Detlofsson, R
    Rasool, O
    Liu, Y
    Söderhäll, S
    Juliusson, G
    Gahrton, G
    Einhorn, S
    BLOOD, 1998, 91 (09) : 3397 - 3400
  • [38] Isolated 6q terminal deletions: An emerging new syndrome
    Bertini, V
    De Vito, G
    Costa, R
    Simi, P
    Valetto, A
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (01) : 74 - 81
  • [39] Development and validation of a prognostic model for Waldenstrom's macroglobulinemia (MW).
    Kyrtsonis, MC
    Dimopoulos, MA
    Vassilakopoulos, TP
    Angelopoulou, MK
    Repoussis, P
    Zervas, K
    Panagiotidis, P
    Siakantaris, MP
    Dimopoulou, MN
    Symeonidis, A
    Bourantas, K
    Vrakidou, E
    Xylouri, E
    Pangalis, GA
    BLOOD, 2003, 102 (11) : 273B - 273B
  • [40] A revised international prognostic score system for Waldenstrom's macroglobulinemia
    Gavriatopoulou, M.
    Kastritis, E.
    Morel, P.
    Duhamel, A.
    Kyrtsonis, M. C.
    Durot, E.
    Symeonidis, A.
    Laribi, K.
    Hatjiharisi, E.
    Ysebaert, L.
    Vassou, A.
    Giannakoulas, N.
    Merlini, G.
    Repousis, P.
    Varettoni, M.
    Michalis, E.
    Hivert, B.
    Michalis, M.
    Leblond, V.
    Dimopoulos, M. A. C.
    ANNALS OF ONCOLOGY, 2018, 29
12345